Is Lamivudine Tablet (Epivir) in shortage?
Lamivudine Tablet is listed by FDA as being discontinued by at least one maker (updated Oct 19, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Epivir, Tablet, 150 mg (NDC 49702-203-18)
The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug
Maker contact: 800-844-8872
- Epivir, Tablet, 300 mg (NDC 49702-204-13)
The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug
Maker contact: 800-844-8872
FDA recalls of Lamivudine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Lamivudine Tablet:
Other forms on FDA’s list
Lamivudine Tablet shortage questions
Is Lamivudine Tablet (Epivir) in shortage?
Lamivudine Tablet is listed by FDA as being discontinued by at least one maker (updated Oct 19, 2026).
What should I do if I can’t get Lamivudine Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.